Literature DB >> 22820408

Biobehavioral influences on recovery following hematopoietic stem cell transplantation.

Erin S Costanzo1, Mark B Juckett, Christopher L Coe.   

Abstract

Hematopoietic stem cell transplantation (HSCT) is a rigorous therapy that carries significant risk of morbidity and mortality to individuals with hematologic malignancies undergoing this treatment. While relationships between psychosocial factors, immune function, and clinical outcomes have been documented in other cancer populations, similar studies of cancer patients undergoing HSCT have not yet been conducted. The clinical significance of these relationships may be particularly salient in this population given the critical role of a timely immune recovery and optimal immune regulation in preventing infections, mitigating risk for graft-versus-host disease, and eliminating malignant cells, thereby reducing morbidity and mortality. Evidence for the potential role of biobehavioral processes following HSCT is reviewed, mechanisms by which psychosocial factors may influence immune processes relevant to post-transplant outcomes are discussed, and a framework to ground future psychoneuroimmunology (PNI) research in this area is provided. The review suggests that the recovery period following HSCT may provide a "window of opportunity" during which interventions targeting stress-related behavioral factors can influence the survival, health, and well-being of HSCT recipients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22820408      PMCID: PMC3493826          DOI: 10.1016/j.bbi.2012.07.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  43 in total

1.  Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors.

Authors:  M Tanaka; J Honda; Y Imamura; K Shiraishi; K Tanaka; K Oizumi
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes.

Authors:  A Kavelaars; M van de Pol; J Zijlstra; C J Heijnen
Journal:  J Neuroimmunol       Date:  1997-08       Impact factor: 3.478

3.  Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.

Authors:  Michael A Andrykowski; Michelle M Bishop; Elizabeth A Hahn; David F Cella; Jennifer L Beaumont; Marianne J Brady; Mary M Horowitz; Kathleen A Sobocinski; J Douglas Rizzo; John R Wingard
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

4.  Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?

Authors:  E Frick; C Motzke; N Fischer; R Busch; I Bumeder
Journal:  Psychooncology       Date:  2005-09       Impact factor: 3.894

5.  Predictors of posttraumatic growth following bone marrow transplantation for cancer.

Authors:  Michelle R Widows; Paul B Jacobsen; Margaret Booth-Jones; Karen K Fields
Journal:  Health Psychol       Date:  2005-05       Impact factor: 4.267

6.  Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes.

Authors:  M M Khan; P Sansoni; E D Silverman; E G Engleman; K L Melmon
Journal:  Biochem Pharmacol       Date:  1986-04-01       Impact factor: 5.858

Review 7.  Immune restoration following hematopoietic stem cell transplantation: an evolving target.

Authors:  J J Auletta; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

Review 8.  A biobehavioral model of cancer stress and disease course.

Authors:  B L Andersen; J K Kiecolt-Glaser; R Glaser
Journal:  Am Psychol       Date:  1994-05

9.  Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking.

Authors:  F S Dhabhar; B S McEwen
Journal:  Brain Behav Immun       Date:  1997-12       Impact factor: 7.217

Review 10.  Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.

Authors:  L F Porrata; S N Markovic
Journal:  Clin Exp Med       Date:  2004-10       Impact factor: 3.984

View more
  28 in total

1.  Circadian Rhythmicity as a Predictor of Quality of Life in Allogeneic Hematopoietic Cell Transplant Patients.

Authors:  Aasha I Hoogland; Hailey W Bulls; Brian D Gonzalez; Brent J Small; Lianqi Liu; Joseph Pidala; Heather S L Jim; Asmita Mishra
Journal:  J Pain Symptom Manage       Date:  2019-01-31       Impact factor: 3.612

2.  Caregiver Sleep and Patient Neutrophil Engraftment in Allogeneic Hematopoietic Stem Cell Transplant: A Secondary Analysis.

Authors:  Timothy S Sannes; Susan K Mikulich-Gilbertson; Crystal L Natvig; Benjamin W Brewer; Teresa L Simoneau; Mark L Laudenslager
Journal:  Cancer Nurs       Date:  2018 Jan/Feb       Impact factor: 2.592

Review 3.  Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations.

Authors:  Paige Green McDonald; Mary O'Connell; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2013-01-16       Impact factor: 7.217

4.  Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients.

Authors:  Stevan E Hobfoll; James I Gerhart; Alyson K Zalta; Kurrie Wells; John Maciejewski; Henry Fung
Journal:  Psychooncology       Date:  2015-01-27       Impact factor: 3.894

5.  Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).

Authors:  William A Wood; Jennifer Le-Rademacher; Karen L Syrjala; Heather Jim; Paul B Jacobsen; Jennifer M Knight; Muneer H Abidi; John R Wingard; Navneet S Majhail; Nancy L Geller; J Douglas Rizzo; Mingwei Fei; Juan Wu; Mary M Horowitz; Stephanie J Lee
Journal:  Cancer       Date:  2015-10-06       Impact factor: 6.860

6.  Capsule Commentary on Zheng et al., The Role of Spirituality in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Mixed Studies Review.

Authors:  Guru Subramanian Guru Murthy; James Jerkins; Jennifer Knight
Journal:  J Gen Intern Med       Date:  2020-07       Impact factor: 5.128

Review 7.  Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies.

Authors:  Mohamad S Alabdaljabar; Ibrahim N Muhsen; Jennifer M Knight; Karen L Syrjala; Shahrukh K Hashmi
Journal:  Blood Rev       Date:  2020-12-01       Impact factor: 8.250

8.  Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

Authors:  Ludovic Belle; Vivian Zhou; Kara L Stuhr; Margaret Beatka; Emily M Siebers; Jennifer M Knight; Michael W Lawlor; Casey Weaver; Misato Hashizume; Cecilia J Hillard; William R Drobyski
Journal:  JCI Insight       Date:  2017-07-20

9.  Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.

Authors:  Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-23       Impact factor: 5.742

10.  Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Jennifer M Knight; J Douglas Rizzo; Brent R Logan; Tao Wang; Jesusa M G Arevalo; Jeffrey Ma; Steve W Cole
Journal:  Clin Cancer Res       Date:  2015-08-18       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.